laboratory Elea

elea.com

It is an Argentine Laboratory, which since 1939 researches and develops reliable drugs for various medical specialties. Backed by business units with leading brands.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

news image

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More

BUSINESS INSIGHTS

CLINCHOICE RAISES $150 MM SERIES E ROUND FINANCING, FURTHER STRENGTHENING ITS GLOBAL SERVICES CAPABILITIES

ClinChoice | July 05, 2022

news image

Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly Asia Ventures and Apricot Capital. Proceeds of the financing will be used to fund the Company's continued business expansion and innovative service offering worldwide. Recently, ClinChoice announced the successful completion of ...

Read More

PHARMACY MARKET

MEDISCA CHOOSES CREATIO TO SPEED UP OPERATIONS AND INCREASE MARKET SHARE

MEDISCA | June 18, 2021

news image

MEDISCA has chosen Creatio's low-code platform for process management and CRM, the company said today. MEDISCA, a global leader in pharmaceutical compounding, chose Creatio to speed up processes, improve market share among current partners, and boost revenue per employee. MEDISCA assists pharmacists by supplying equipment, devices, and high-quality ingredients. MEDISCA has a good reputation in the pharmaceutical compounding business as an innovative and entrepreneurial company...

Read More

PHARMACY MARKET

TAKEDA IS POISED TO COMMERCIALIZE NEXT GENERATION HUNTER'S DISEASE THERAPY THROUGH COLLABORATION WITH JCR PHARMACEUTICALS

Takeda Pharmaceutical Company Limited | October 01, 2021

news image

Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. today announce a geographically focused exclusive collaboration and license agreement to commercialize JR-141, a recombinant fusion protein under development of a next-generation antibody against the human transferrin receptor and the enzyme iduronate- 2-sulfatase (IDS), used to treat Hunter's disease (also called mucopolysaccharidosis type II or MPS II). Hunter's disease is caused by the lack of IDS and manifests it...

Read More
news image

BUSINESS INSIGHTS

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More
news image

BUSINESS INSIGHTS

CLINCHOICE RAISES $150 MM SERIES E ROUND FINANCING, FURTHER STRENGTHENING ITS GLOBAL SERVICES CAPABILITIES

ClinChoice | July 05, 2022

Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly Asia Ventures and Apricot Capital. Proceeds of the financing will be used to fund the Company's continued business expansion and innovative service offering worldwide. Recently, ClinChoice announced the successful completion of ...

Read More
news image

PHARMACY MARKET

MEDISCA CHOOSES CREATIO TO SPEED UP OPERATIONS AND INCREASE MARKET SHARE

MEDISCA | June 18, 2021

MEDISCA has chosen Creatio's low-code platform for process management and CRM, the company said today. MEDISCA, a global leader in pharmaceutical compounding, chose Creatio to speed up processes, improve market share among current partners, and boost revenue per employee. MEDISCA assists pharmacists by supplying equipment, devices, and high-quality ingredients. MEDISCA has a good reputation in the pharmaceutical compounding business as an innovative and entrepreneurial company...

Read More
news image

PHARMACY MARKET

TAKEDA IS POISED TO COMMERCIALIZE NEXT GENERATION HUNTER'S DISEASE THERAPY THROUGH COLLABORATION WITH JCR PHARMACEUTICALS

Takeda Pharmaceutical Company Limited | October 01, 2021

Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. today announce a geographically focused exclusive collaboration and license agreement to commercialize JR-141, a recombinant fusion protein under development of a next-generation antibody against the human transferrin receptor and the enzyme iduronate- 2-sulfatase (IDS), used to treat Hunter's disease (also called mucopolysaccharidosis type II or MPS II). Hunter's disease is caused by the lack of IDS and manifests it...

Read More